Back to Agenda
Our First Year Under Sunshine: Impact on Medical and Scientific Communications
Session Chair(s)
Monica Kwarcinski, PHARMD
Vice President, Medical Affairs, Purdue Pharma L.P., United States
Having passed the one-year milestone of the Physician Payments Sunshine Act, industry continues to evaluate and tweak internal processes on collecting the required data and anxiously awaits the publishing of these data on a publicly available website. This session will describe the obligations, challenges, and impact the Sunshine Act has had on industry medical information departments, medical science liaisons, and medical writers as well as industry sponsored publications. This will be an interactive session with opportunity for discussion and questions from the audience.
Learning Objective : Describe key elements to the Physician Payments Sunshine Act; Describe the specific obligations under the Sunshine Act that affect medical communication, medical science liaisons, and medical writing departments within industry; Identify challenges and considerations for medical and scientific communications departments related to the Sunshine Act; Discuss examples of reprint values and the basis of those values.
Speaker(s)
Monica Kwarcinski, PHARMD
Vice President, Medical Affairs, Purdue Pharma L.P., United States
The Sunshine Act and Medical Communications
Kathleen M Guindon, PHD, MS, RN
Senior Director, Medical Science Liaison, Kronos Bio, United States
The Sunshine Act and The Medical Science Liaison
Kim Pepitone
Scientific Director, Cactus Communications, Inc., United States
Deconstructing Sunshine for Medical Writers and Publication Professionals
Have an account?